BD, Techcyte to offer AI-based digital cervical cytology system for pap testing
Singapore, Jan. 31 -- BD (Becton, Dickinson and Company), US-based medical technology company, and Techcyte, a world leader in artificial intelligence (AI)-based digital diagnostics, have announced a strategic collaboration agreement to offer an AI-based algorithm that guides cytologists and pathologists to efficiently and effectively identify evidence of cervical cancer and precancer using whole-slide imaging.
The agreement enables BD to deliver a complete solution that aims to reduce the potential for human error and enable greater throughput, so that labs can achieve their results with greater standardisation, reproducibility, and efficiency from a Pap test, also known as a Pap smear.
Traditionally, Pap tests have been conducted by t...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.